Abeona Therapeutics Inc.

NASDAQ: ABEO · Real-Time Price · USD
7.12
-0.11 (-1.52%)
At close: Aug 15, 2025, 3:59 PM
7.13
0.14%
After-hours: Aug 15, 2025, 06:57 PM EDT

Abeona Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 2.82M 2.82M 6.32M 6.32M 3.57M 3.57M 1.07M 1.41M 4.35M 4.35M 3.35M 3M 3M 10M 10M
Cost of Revenue
1.67M 2.39M 3.11M 3.48M 2.65M 2.82M 2.19M 1.83M 1.34M 1.56M 2.66M 3.74M 4.49M 4.46M 3.27M 10.15M 15.16M
Gross Profit
-1M -1.72M 464K 95K 2.98M -4.34M -5.78M -5.41M -7.42M -149K 1.69M -7.37M -16.55M -24.1M -32.15M -24.06M -16.61M
Operating Income
-69.61M -64.21M -60.75M -56.74M -49.43M -47.13M -46.86M -44.91M -42.36M -50.91M -52.16M -57.66M -63.36M -57.37M -57.66M -49.04M -47.81M
Interest Income
4.71M 4.25M 3.97M 3.37M 2.6M 2.12M 1.7M 1.18M 795K 438K 146K 84K 61K 69K 73K 401K 664K
Pretax Income
-44.19M -63.73M -71.03M -52.6M -76.66M -54.19M -38.72M -36.37M -23.81M -35.5M -81.06M -78.61M -89.72M -84.94M -54.08M -54.27M -52.08M
Net Income
-44.19M -63.73M -71.03M -52.6M -76.66M -54.19M -38.72M -36.37M -23.81M -36.75M -82.31M -79.87M -90.98M -84.94M -54.08M -54.27M -52.08M
Selling & General & Admin
32.51M 29.85M 28M 25.75M 22.13M 19M 18.86M 18.59M 17.03M 17.26M 16.25M 18.18M 20.18M 22.52M 25.24M 23.85M 23.93M
Research & Development
37.09M 34.36M 32.74M 30.95M 30.26M 31.09M 29.98M 28.33M 26.46M 28.96M 34.39M 37.99M 38.77M 35.43M 32.97M 31.86M 30.53M
Other Expenses
n/a n/a n/a n/a n/a -888K -888K -888K -888K n/a -389K -1.22M -1.5M -1.76M -1.37M -7.67M -12.66M
Operating Expenses
69.61M 64.21M 60.75M 56.71M 52.39M 49.21M 47.95M 46.03M 42.6M 46.22M 50.26M 54.95M 57.45M 56.19M 56.84M 48.05M 41.8M
Interest Expense
4.25M 4.21M 3.23M 2.24M 1.27M 418K 487K 539K 636K 736K 625K 1.15M 2.45M 3.67M 4.99M 5.63M 4.93M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
69.61M 64.21M 60.75M 56.74M 52.93M 50.63M 49.48M 47.53M 43.94M 46.67M 51.8M 57.3M 60.54M 60.37M 60.66M 59.04M 57.81M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 200K 267K 267K 275K 90K 63K 63K 55K
Shares Outstanding (Basic)
49.78M 41.05M 48.08M 40.01M 27.32M 25.56M 24.8M 18.02M 16.9M 7.14M 6.42M 5.81M 5.79M 4.19M 3.92M 3.87M 3.77M
Shares Outstanding (Diluted)
49.78M 41.05M 48.08M 51.23M 27.32M 25.56M 24.8M 18.02M 16.9M 7.14M 6.42M 5.81M 5.79M 4.19M 3.92M 3.87M 3.77M
EPS (Basic)
-0.91 -1.83 -2.25 -2.1 -3.21 -2.59 -2.47 -2.99 -3.43 -6.69 -17.31 -18.11 -20.68 -21.13 -14.24 -14.39 -13.96
EPS (Diluted)
-0.96 -1.88 -2.3 -2.15 -3.21 -2.59 -2.47 -2.99 -3.43 -6.69 -17.31 -18.11 -20.68 -21.13 -14.24 -14.39 -13.96
EBITDA
-36.93M -56.62M -64.94M -47.48M -72.36M -50.57M -34.75M -32.01M -22.91M -35.38M -80.86M -77.9M -83.9M -76.8M -44.98M -44.77M -43.28M
EBIT
-39.93M -59.53M -67.8M -50.36M -75.39M -53.77M -38.24M -35.83M -27.26M -38.84M -84.51M -81.55M -87.27M -81.27M -49.09M -48.64M -47.14M
Depreciation & Amortization
3M 2.91M 2.85M 2.88M 3.03M 3.2M 3.49M 3.82M 4.35M 4.58M 4.76M 4.76M 4.49M 4.46M 4.11M 3.87M 3.86M